Please login to the form below

Not currently logged in
Email:
Password:

loss of exclusivity

This page shows the latest loss of exclusivity news and features for those working in and with pharma, biotech and healthcare.

New data keeps AbbVie’s star pipeline therapies on track

New data keeps AbbVie’s star pipeline therapies on track

when it came to keeping patients in work without loss of productivity caused by the skin disorder. ... The prospects for risankizumab and upadacitinib matter for AbbVie because it’s well-recognised that the loss of exclusivity for Humira after 2022 in

Latest news

  • Daily Brief: Biosimilars ready to pounce on Humira, Hong Kong could rival Nasdaq, Kymab's OX40 candidate Daily Brief: Biosimilars ready to pounce on Humira, Hong Kong could rival Nasdaq, Kymab's OX40 candidate

    Biosimilar companies are now gearing up to pounce on AbbVie’s inflammation blockbuster Humira (adalimumab) when it loses its patent exclusivity across Europe on 16 October. ... As the potential savings are so great, NHS England’s Commercial Medicines

  • Pfizer builds gap between pharma and consumer health units Pfizer builds gap between pharma and consumer health units

    Its consumer health division will become a standalone unit after lack of buyer interest. ... the loss of market exclusivity for older, big-selling drugs.

  • The new basics The new basics

    This is most immediately obvious in the first - the threat of lost reputation. ... This beneficial combination of factors seems to be changing however. Profit streams erode quickly with loss of exclusivity of blockbusters and even patented products face

  • Sweet emotion Sweet emotion

    Branded medication continues to get prescribed even after loss of exclusivity. ... In the pharma sector specifically, we know branded medication continues to get prescribed even after loss of exclusivity.

  • Learning from forecasting's past Learning from forecasting's past

    Contraction in economies, pressure on pharmaceutical prices, increasing competitive pressure, and loss of marketing exclusivity on major products drove the need for more accurate planning and forecasting. ... One key driver of uncertainty is the loss of

More from news
Approximately 0 fully matching, plus 52 partially matching documents found.

Latest Intelligence

  • Back to the future Back to the future

    The loss of exclusivity for Lipitor continued to have a major impact, but alongside this, a further 24 of its therapies suffered a drop in sales. ... in an attempt to mirror the success of Roche and its Genentech subsidiary.”.

  • Who tops the pharma list? Who tops the pharma list?

    Loss of exclusivity on some of its leading brands - not least Lipitor - contributed to an overall dip in revenue of more than $6.5bn from 2011. ... In fact, patent expiry was an industry-wide epidemic in 2011/12, with loss of exclusivity plaguing many of

  • Interview: Trevor Smith, Takeda Interview: Trevor Smith, Takeda

    Major products were about to lose, or had just lost, their patent exclusivity.”. ... For Nycomed this meant loss of exclusivity (LOE) on its blockbuster gastroinestinal drug pantoprazole and the consequent need to reorganise its business.

  • The true meaning of market access? The true meaning of market access?

    Appropriate patients. Payers want predictability of patient outcomes and certainty of budget impact. ... Market access is everyone's responsibility throughout the life of the medicine from early phase R&D right through to loss of exclusivity.  .

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 9 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

01 PME-APR21 Cover.jpg
Virtual congresses: video thrilled the cardio tsar
Chris Ross explores the key learnings from a year of virtual congresses...
When Will We Be Back To Normal?
The definitive question of 2021, whether you’re a homeschooling parent, a homebound professional, a wanderer with nowhere to go… or all three at once....
How to tell your healthcare story.
Healthcare research is not a simple story and the people in charge of those moments need to be careful about the story that they tell....

Infographics